Pharmaceutical Patents and its Affects on Generic Market
|Event Date/Time: Mar 16, 2007|
Western pharmaceutical companies now defend their brands very aggressively. As the number of NCEs coming to market shrinks, the importance of defending a blockbuster product increases and multinationals are becoming more active in finding ways to deter generic competition.
Many of the defence strategies involve the use of patents and data exclusivity to protect leading products. It is therefore vital to understand the importance of these topics in order to be prepared for potential barriers to the introduction of a generic copy of a major brand. These issues have a direct impact on the regulatory and commercial strategies of any planned generic launch and making a mistake can lead to expensive consequences.
Why should attend? :
Intellectual property is a major factor in Western generic markets and a major defence tool for branded companies
The way in which patents and data exclusivity interconnect is potentially very complicated and hard to understand
Local variations at a national level mean that there is not just one solution that works everywhere across Europe
An understanding of these issues is vital for companies wanting to enter these markets
The costs of making a mistake can be very high in legal costs and delays in reaching the market
This seminar will highlight the major issues in Europe and the USA and provide you with a good basic understanding
It will help you to avoid expensive pitfalls and costly mistakes and delays